Epigenetic mechanisms in heart development and disease

Drug Discovery Today

Volumn 20, Issue 7, 2015, Pages 799-811

  Martinez, Shannalee R ^a   Gay, Maresha S ^a   Zhang, Lubo ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; CARDIOVASCULAR AGENT; GENETIC MARKER;

ARTICLE; ATHEROSCLEROSIS; BIOGENESIS; CARDIOMYOGENESIS; CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DNA METHYLATION; ENZYME REGULATION; EPIGENETICS; HEART ARRHYTHMIA; HEART DEVELOPMENT; HEART DISEASE; HISTONE MODIFICATION; HUMAN; HYPERTENSION; MUSCLE DEVELOPMENT; NONHUMAN; ANIMAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; DRUG EFFECTS; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC EPIGENESIS; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART; HEART DISEASES; MORPHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE;

ANIMALS; CARDIOVASCULAR AGENTS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC THERAPY; HEART; HEART DISEASES; HUMANS; MICRORNAS; MORPHOGENESIS; PHENOTYPE;

EID: 84936847413     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.12.018     Document Type: Review

References (151)

1. D.J. Barker, and C. Osmond Low birth weight and hypertension BMJ 297 1988 134 135
2. M. Chen, and L. Zhang Epigenetic mechanisms in developmental programming of adult disease Drug Discov. Today 16 2011 1007 1018
3. C.N. Hales, and D.J. Barker The thrifty phenotype hypothesis Br. Med. Bull. 60 2001 5 20
4. C.P. Chang, and B.G. Bruneau Epigenetics and cardiovascular development Annu. Rev. Physiol. 74 2012 41 68
5. L. Ho, and G.R. Crabtree Chromatin remodelling during development Nature 463 2010 474 484
6. Z.D. Smith, and A. Meissner DNA methylation: roles in mammalian development Nat. Rev. Genet. 14 2013 204 220
7. B.A. Buck-Koehntop, and P.A. Defossez On how mammalian transcription factors recognize methylated DNA Epigenetics 8 2013 131 137
8. L.D. Moore DNA methylation and its basic function Neuropsychopharmacology 38 2013 23 38
9. G.C. Hon Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues Nat. Genet. 45 2013 1198 1206
10. S. Saxonov A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters Proc. Natl. Acad. Sci. U. S. A. 103 2006 1412 1417
11. T.S. Mikkelsen Genome-wide maps of chromatin state in pluripotent and lineage-committed cells Nature 448 2007 553 560
12. K.L. Nazor Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives Cell Stem Cell 10 2012 620 634
13. M.J. Boland Epigenetic regulation of pluripotency and differentiation Circ. Res. 115 2014 311 324
14. F. Brenet DNA methylation of the first exon is tightly linked to transcriptional silencing PLoS ONE 6 2011 e14524
15. S. Shukla CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing Nature 479 2011 74 79
16. A.K. Maunakea Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition Cell Res. 23 2013 1256 1269
17. S. Seisenberger Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers Philos. Trans. R. Soc. Lond. B: Biol. Sci. 368 2013 20110330
18. S. Guibert Global profiling of DNA methylation erasure in mouse primordial germ cells Genome Res. 22 2012 633 641
19. G. Auclair, and M. Weber Mechanisms of DNA methylation and demethylation in mammals Biochimie 94 2012 2202 2211
20. S. Guibert, and M. Weber Functions of DNA methylation and hydroxymethylation in mammalian development Curr. Top. Dev. Biol. 104 2013 47 83
21. K. Luger Crystal structure of the nucleosome core particle at 2.8 Å resolution Nature 389 1997 251 260
22. B.D. Strahl, and C.D. Allis The language of covalent histone modifications Nature 403 2000 41 45
23. A. Vaquero The constantly changing face of chromatin Sci. Aging Knowl. Environ. 2003 2003 Re4
24. B. Li The role of chromatin during transcription Cell 128 2007 707 719
25. Y. Wang Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseases Oxid. Med. Cell Longev. 2014 2014 641979
26. A.J. Bannister, and T. Kouzarides Regulation of chromatin by histone modifications Cell Res. 21 2011 381 395
27. M. Dokmanovic Histone deacetylase inhibitors: overview and perspectives Mol. Cancer Res. 5 2007 981 989
28. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
29. K.C. Vickers MicroRNAs in the onset and development of cardiovascular disease Clin. Sci. (Lond.) 126 2014 183 194
30. O.A. Berillo Characteristics of binding sites of intergenic, intronic and exonic miRNAs with mRNAs of oncogenes coding intronic miRNAs Afr. J. Biotechnol. 12 2013 1016 1024
31. H. Guo Mammalian microRNAs predominantly act to decrease target mRNA levels Nature 466 2010 835 840
32. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
33. A.J. Pratt, and I.J. MacRae The RNA-induced silencing complex: a versatile gene-silencing machine J. Biol. Chem. 284 2009 17897 17901
34. D. Srivastava Making or breaking the heart: from lineage determination to morphogenesis Cell 126 2006 1037 1048
35. M. Xin Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair Nat. Rev. Mol. Cell Biol. 14 2013 529 541
36. A.N. Paradis Binucleation of cardiomyocytes: the transition from a proliferative to a terminally differentiated state Drug Discov. Today 19 2014 602 609
37. T. Nuhrenberg Epigenetics in cardiac development, function, and disease Cell Tissue Res. 356 2014 585 600
38. J. Arand In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases PLoS Genet. 8 2012 e1002750
39. R. Hirasawa Maternal and zygotic Dnmt1 are necessary and sufficient for the maintenance of DNA methylation imprints during preimplantation development Genes Dev. 22 2008 1607 1616
40. Y. Kurihara Maintenance of genomic methylation patterns during preimplantation development requires the somatic form of DNA methyltransferase 1 Dev. Biol. 313 2008 335 346
41. H. Lei De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells Development 122 1996 3195 3205
42. M. Okano DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development Cell 99 1999 247 257
43. J. Borgel Targets and dynamics of promoter DNA methylation during early mouse development Nat. Genet. 42 2010 1093 1100
44. M.M. Dawlaty Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development Cell Stem Cell 9 2011 166 175
45. S. Yamaguchi Tet1 controls meiosis by regulating meiotic gene expression Nature 492 2012 443 447
46. M. Ko Ten-eleven-translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice Proc. Natl. Acad. Sci. U. S. A. 108 2011 14566 14571
47. Z. Li Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies Blood 118 2011 4509 4518
48. K. Moran-Crusio Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation Cancer Cell 20 2011 11 24
49. C. Quivoron TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis Cancer Cell 20 2011 25 38
50. T.P. Gu The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes Nature 477 2011 606 610
51. M.K. Choy Genome-wide conserved consensus transcription factor binding motifs are hyper-methylated BMC Genomics 11 2010 519
52. L. Laurent Dynamic changes in the human methylome during differentiation Genome Res. 20 2010 320 331
53. M. Bibikova Human embryonic stem cells have a unique epigenetic signature Genome Res. 16 2006 1075 1083
54. D. Abbey, and P.B. Seshagiri Aza-induced cardiomyocyte differentiation of P19 EC-cells by epigenetic co-regulation and ERK signaling Gene 526 2013 364 373
55. A.A. Chamberlain DNA methylation is developmentally regulated for genes essential for cardiogenesis J. Am. Heart Assoc. 3 2014 e000976
56. A. Paradis Endothelin-1 promotes cardiomyocyte terminal differentiation in the developing heart via heightened DNA methylation Int. J. Med. Sci. 11 2014 373 380
57. C.Y. Kou Epigenetic regulation of neonatal cardiomyocytes differentiation Biochem. Biophys. Res. Commun. 400 2010 278 283
58. Y. Yuan Promoter methylation and expression of the VANGL2 gene in the myocardium of pediatric patients with Tetralogy of Fallot Birth Defects Res. A: Clin. Mol. Teratol. 2014 10.1002/bdra.23291
59. T.P. Yao Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300 Cell 93 1998 361 372
60. N. Shikama Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation EMBO J. 22 2003 5175 5185
61. R.L. Montgomery Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility Genes Dev. 21 2007 1790 1802
62. R.L. Montgomery Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice J. Clin. Invest. 118 2008 3588 3597
63. S. Chang Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development Mol. Cell Biol. 24 2004 8467 8476
64. P.D. Gottlieb Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis Nat. Genet. 31 2002 25 32
65. D. Srivastava A subclass of bHLH proteins required for cardiac morphogenesis Science 270 1995 1995 1999
66. Y. Lee Jumonji, a nuclear protein that is necessary for normal heart development Circ. Res. 86 2000 932 938
67. J. Jung Jumonji regulates cardiomyocyte proliferation via interaction with retinoblastoma protein J. Biol. Chem. 280 2005 30916 30923
68. J.E. Schneider Identification of cardiac malformations in mice lacking Ptdsr using a novel high-throughput magnetic resonance imaging technique BMC Dev. Biol. 4 2004 16
69. J. Wang Opposing LSD1 complexes function in developmental gene activation and repression programmes Nature 446 2007 882 887
70. T.B. Nicholson A hypomorphic lsd1 allele results in heart development defects in mice PLOS ONE 8 2013 e60913
71. E. Wienholds MicroRNA expression in zebrafish embryonic development Science 309 2005 310 311
72. J.F. Chen The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation Nat. Genet. 38 2006 228 233
73. P.K. Rao Myogenic factors that regulate expression of muscle-specific microRNAs Proc. Natl. Acad. Sci. U. S. A. 103 2006 8721 8726
74. A. Care MicroRNA-133 controls cardiac hypertrophy Nat. Med. 13 2007 613 618
75. C. Kwon MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling Proc. Natl. Acad. Sci. U. S. A. 102 2005 18986 18991
76. B. Yang The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 Nat. Med. 13 2007 486 491
77. N. Liu microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart Genes Dev. 22 2008 3242 3254
78. J.P. Sluijter MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells Arterioscler. Thromb. Vasc. Biol. 30 2010 859 868
79. E. van Rooij, and E.N. Olson MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets J. Clin. Invest. 117 2007 2369 2376
80. B. Duygu Genetics and epigenetics of arrhythmia and heart failure Front. Genet. 4 2013 219
81. E. Dirkx Regulation of fetal gene expression in heart failure Biochim. Biophys. Acta 1832 2013 2414 2424
82. E. Bronze-da-Rocha MicroRNAs expression profiles in cardiovascular diseases Biomed. Res. Int. 2014 2014 985408
83. E.E. Creemers Heart failure: advances through genomics Nat. Rev. Genet. 12 2011 357 362
84. A.S. Go Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
85. I. Smolarek Global DNA methylation changes in blood of patients with essential hypertension Med. Sci. Monit. 16 2010 Cr149 Cr155
86. S. Friso Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension Atherosclerosis 199 2008 323 327
87. P.M. Stewart Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle J. Clin. Invest. 82 1988 340 349
88. S. Friso Epigenetics and arterial hypertension: the challenge of emerging evidence Transl. Res. 165 2015 154 165
89. G. Riviere Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation Epigenetics 6 2011 478 489
90. R. Papait Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy Proc. Natl. Acad. Sci. U. S. A. 110 2013 20164 20169
91. B. Rodriguez-Iturbe Arteriolar remodeling in essential hypertension: are connective tissue growth factor and transforming growth factor involved? Kidney Int. 69 2006 1104 1105
92. D. Zhang Epigenetics and the control of epithelial sodium channel expression in collecting duct Kidney Int. 75 2009 260 267
93. L.H. Pojoga Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension Am. J. Physiol. Heart Circ. Physiol. 301 2011 H1862 H1871
94. M.K. Irmak, and A. Sizlan Essential hypertension seems to result from melatonin-induced epigenetic modifications in area postrema Med. Hypotheses 66 2006 1000 1007
95. A. Nguyen Dinh Cat Conditional transgenic mice for studying the role of the glucocorticoid receptor in the renal collecting duct Endocrinology 150 2009 2202 2210
96. S. Mu Epigenetic modulation of the renal beta-adrenergic-WNK4 pathway in salt-sensitive hypertension Nat. Med. 17 2011 573 580
97. S. Albinsson, and K. Sward Targeting smooth muscle microRNAs for therapeutic benefit in vascular disease Pharmacol. Res. 75 2013 28 36
98. X. Luo Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications Cell Physiol. Biochem. 25 2010 571 586
99. S.J. Matkovich MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts Circ. Res. 106 2010 166 175
100. V.K. Topkara, and D.L. Mann Clinical applications of miRNAs in cardiac remodeling and heart failure Per. Med. 7 2010 531 548
101. S. Ikeda MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes Mol. Cell Biol. 29 2009 2193 2204
102. L. Elia Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions Circulation 120 2009 2377 2385
103. E. Hergenreider Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs Nat. Cell Biol. 14 2012 249 256
104. L. Elia The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease Cell Death Differ. 16 2009 1590 1598
105. E. van Rooij A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure Proc. Natl. Acad. Sci. U. S. A. 103 2006 18255 18260
106. S. Dong MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction J. Biol. Chem. 284 2009 29514 29525
107. Y. Cheng MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am. J. Pathol. 170 2007 1831 1840
108. T. Thum MicroRNAs: novel regulators in cardiac development and disease Cardiovasc. Res. 79 2008 562 570
109. R. Ji MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation Circ. Res. 100 2007 1579 1588
110. D.M. Patrick Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice J. Clin. Invest. 120 2010 3912 3916
111. J. Haas Alterations in cardiac DNA methylation in human dilated cardiomyopathy EMBO Mol. Med. 5 2013 413 429
112. M. Movassagh Distinct epigenomic features in end-stage failing human hearts Circulation 124 2011 2411 2422
113. A.T. Nguyen DOT1L regulates dystrophin expression and is critical for cardiac function Genes Dev. 25 2011 263 274
114. B. Zhou Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy Clin. Chim. Acta 411 2010 1287 1290
115. S.J. Matkovich Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy Circ. Res. 111 2012 521 531
116. J. Halkein MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy J. Clin. Invest. 123 2013 2143 2154
117. K.L. Fan Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy Indian Heart J. 65 2013 12 16
118. M. Satoh Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy J. Card. Fail. 16 2010 404 410
119. G.H. Kim MicroRNA regulation of cardiac conduction and arrhythmias Transl. Res. 161 2013 381 392
120. T.E. Callis MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice J. Clin. Invest. 119 2009 2772 2786
121. Y. Lu MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation Circulation 122 2010 2378 2387
122. P. Libby Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
123. R. Castro Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease Clin. Chem. 49 2003 1292 1296
124. M.O. Hiltunen DNA hypomethylation and methyltransferase expression in atherosclerotic lesions Vasc. Med. 7 2002 5 11
125. A.K. Ying Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells Cardiovasc. Res. 46 2000 172 179
126. A. Baccarelli Ischemic heart disease and stroke in relation to blood DNA methylation Epidemiology 21 2010 819 828
127. D.M. Fass Effect of inhibiting histone deacetylase with short-chain carboxylic acids and their hydroxamic acid analogs on vertebrate development and neuronal chromatin ACS Med. Chem. Lett. 2 2010 39 42
128. J.P. Cardinale HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats Hypertension 56 2010 437 444
129. H.M. Findeisen Epigenetic regulation of vascular smooth muscle cell function in atherosclerosis Curr. Atheroscler. Rep. 15 2013 319
130. M.S. Yan Epigenetics of the vascular endothelium J. Appl. Physiol. 109 2010 916 926
131. J.J. Ho Nitric oxide signaling in hypoxia J. Mol. Med. (Berl.) 90 2012 217 231
132. J. Wang Altered serum microRNAs as novel diagnostic biomarkers for atypical coronary artery disease PLOS ONE 9 2014 e107012
133. Y. Wei MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis? Arterioscler. Thromb. Vasc. Biol. 33 2013 449 454
134. R. Menghini MicroRNAs in vascular aging and atherosclerosis Ageing Res. Rev. 17 2014 68 78
135. I. Faraoni miR-155 gene: a typical multifunctional microRNA Biochim. Biophys. Acta 1792 2009 497 505
136. Y. Fang MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro Proc. Natl. Acad. Sci. U. S. A. 107 2010 13450 13455
137. N. Zhu Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration Atherosclerosis 215 2011 286 293
138. S. Fichtlscherer Circulating microRNAs in patients with coronary artery disease Circ. Res. 107 2010 677 684
139. X. Ma MicroRNA-155 in the pathogenesis of atherosclerosis: a conflicting role? Heart Lung Circ. 22 2013 811 818
140. K.J. Rayner MiR-33 contributes to the regulation of cholesterol homeostasis Science 328 2010 1570 1573
141. K.J. Rayner Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis J. Clin. Invest. 121 2011 2921 2931
142. N. Naeem DNA methylation inhibitors, 5-azacytidine and zebularine potentiate the transdifferentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes Cardiovasc. Ther. 31 2013 201 209
143. P. Antonitsis In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine Interact. Cardiovasc. Thorac. Surg. 6 2007 593 597
144. Q. Qian 5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase Stem Cells Dev. 21 2012 67 75
145. E. Martin-Rendon 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies Vox. Sang. 95 2008 137 148
146. A. Horrillo Zebularine regulates early stages of mESC differentiation: effect on cardiac commitment Cell Death Dis. 4 2013 e570
147. H. Tao Histone deacetylases in cardiac fibrosis: current perspectives for therapy Cell. Signal. 26 2014 521 527
148. K.B. Schuetze Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs J. Mol. Cell. Cardiol. 70 2014 100 107
149. A.S. Sayed Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases Heart Lung Circ. 23 2014 503 510
150. R.L. Montgomery Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure Circulation 124 2011 1537 1547
151. V. Sala MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine Cell. Mol. Life Sci. 71 2014 1439 1452